Standard Biotools (LAB) Net Cash Flow Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | -54.17% |
| 10 | Standard Biotools | 258.06 Mn | -218.66 Mn | 10.54 Mn | -42.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -42.99% |
| Mar 31, 2026 | 1,019.85% |
| Dec 31, 2025 | 79.91% |
| Sep 30, 2025 | 50.65% |
| Jun 30, 2025 | 140.48% |
| Mar 31, 2025 | -106.66% |
| Dec 31, 2024 | -52.06% |
| Sep 30, 2024 | 6.00% |
| Jun 30, 2024 | -159.75% |
| Mar 31, 2024 | 634.53% |
| Dec 31, 2023 | -235.52% |
| Sep 30, 2023 | -350.30% |
| Jun 30, 2023 | -35.81% |
| Mar 31, 2023 | 1,885.84% |
| Sep 30, 2022 | 64.59% |
| Jun 30, 2022 | 218.27% |
| Mar 31, 2022 | 108.58% |
| Sep 30, 2021 | -235.03% |
| Jun 30, 2021 | -581.95% |
| Mar 31, 2021 | -248.87% |